Drugs / 7.2% NaCl plus 6% hydroxyethyl starch 200/0.5
7.2% NaCl plus 6% hydroxyethyl starch 200/0.5
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01675453 Comparator | Jan → Sep 2012 | coronary artery disorder | Meshalkin Research Institute of Pathology of Circulation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 7.2% NaCl plus 6% hydroxyethyl starch 200/0.5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01675453 ↗ |
| Modality | Other / unclassified | “Hypertonic solution creates an osmotic gradient across the cellular membrane” NCT01675453 ↗ |
| Route | Intravenous | “4 mL/kg for 30 min, IV (in the vein), once” NCT01675453 ↗ |